This is GIVETAXFREE.ORG! Start your campaign now! ✨
This is GIVETAXFREE.ORG! Start your campaign now! ✨
givetaxfree.org

Preventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma [Video]

Categories
Skin Cancer

Preventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma

Host: Jason J. Luke, MD, FACP

Guest: Tara C. Mitchell, MD

The 5-year recurrence rates for stage IIB and IIC melanoma are up to 46%, but now new immunotherapy options are FDA-approved for the adjuvant treatment of stage IIB and IIC melanoma. Find out why this matters and hear Drs. Jason Luke and Tara Mitchell break down the latest data on treating stage IIB and IIC melanoma with adjuvant immunotherapy.

FAQs About GiveTaxFree Answered! PART II
FAQs About GiveTaxFree Answered! PART II
givetaxfree.org